Sarepta Therapeutics, Inc. (SRPT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$16.57
Day's range
$17.71

Sarepta Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 14.28 M $307.38 M   8.21% 14.25%
VANGUARD GROUP INC 01/29/2026 11.81 M $254.17 M   9.18% 11.78%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 7.80 M $167.78 M   454.65% 7.78%
STATE STREET CORP 02/13/2026 6.60 M $142.02 M   24.40% 6.58%
ERSTE ASSET MANAGEMENT GMBH 02/11/2026 2.73 M $58.73 M   1.60% 2.72%
TWO SIGMA INVESTMENTS, LP 02/17/2026 2.44 M $52.54 M   14.21% 2.44%
ABRDN PLC 01/16/2026 2.25 M $48.45 M   13.56% 2.25%
TWO SIGMA ADVISERS, LP 02/17/2026 2.07 M $44.58 M   5.79% 2.07%
UBS GROUP AG 01/29/2026 2.06 M $44.30 M   3.43% 2.05%
FIRST TRUST ADVISORS LP 02/13/2026 1.99 M $42.88 M   2.72% 1.99%
MORGAN STANLEY 02/13/2026 1.91 M $41.16 M   -1.83% 1.91%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.90 M $40.99 M   10.64% 1.90%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.69 M $36.47 M   111.02% 1.69%
D. E. SHAW & CO., INC. 02/17/2026 1.54 M $33.15 M   -23.25% 1.54%
LMR PARTNERS LLP 02/17/2026 1.45 M $31.26 M   5.10% 1.45%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 1.45 M $31.14 M   4.00% 1.44%
FEDERATED HERMES, INC. 02/12/2026 1.31 M $28.26 M   0.35% 1.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 1.18 M $25.32 M   5.43% 1.17%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.16 M $24.95 M   -56.25% 1.16%
CITIGROUP INC 02/13/2026 1.15 M $24.67 M   12.49% 1.14%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 1.08 M $23.30 M   -37.95% 1.08%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.00 M $21.52 M   251.89% 1.00%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/19/2026 892.07 K $19.20 M   -34.73% 0.89%
VOLEON CAPITAL MANAGEMENT LP 02/17/2026 879.95 K $18.94 M   75.59% 0.88%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 878.39 K $18.90 M   -32.88% 0.88%
WHITEBOX ADVISORS LLC 02/17/2026 810.80 K $17.45 M   0.00% 0.81%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 810.00 K $17.43 M   -18.18% 0.81%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 765.38 K $16.47 M   25.65% 0.76%
JPMORGAN CHASE & CO 02/11/2026 743.99 K $16.01 M   11.15% 0.74%
NORTHERN TRUST CORP 02/17/2026 733.43 K $15.78 M   14.82% 0.73%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 727.79 K $15.66 M   -59.14% 0.73%
BANK OF NEW YORK MELLON CORP 02/10/2026 691.03 K $14.87 M   17.07% 0.69%
GOLDMAN SACHS GROUP INC 03/25/2026 563.49 K $12.13 M   218.08% 0.56%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 553.38 K $11.91 M   110.95% 0.55%
CITADEL ADVISORS LLC 02/17/2026 505.10 K $10.87 M   -17.28% 0.50%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 497.28 K $10.70 M   6.24% 0.50%
C WORLDWIDE GROUP HOLDING A/S 02/04/2026 490.33 K $10.55 M   0.00% 0.49%
CAPITAL FUND MANAGEMENT S.A. 02/17/2026 485.45 K $10.45 M   -37.77% 0.48%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 02/13/2026 479.25 K $10.31 M   100.00% 0.48%
IEQ CAPITAL, LLC 02/13/2026 475.00 K $10.22 M   597.76% 0.47%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 458.15 K $9.86 M   -29.69% 0.46%
CITADEL ADVISORS LLC 02/17/2026 437.50 K $9.42 M   -34.45% 0.44%
CLEAR STREET GROUP INC. 02/13/2026 433.00 K $9.32 M   100.00% 0.43%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 427.61 K $9.20 M   -56.84% 0.43%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 02/11/2026 400.00 K $8.61 M   100.00% 0.40%
INVESCO LTD. 02/19/2026 397.00 K $8.54 M   -52.32% 0.40%
NORGES BANK 02/10/2026 370.70 K $7.98 M   100.00% 0.37%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 362.67 K $7.80 M   -4.85% 0.36%
LMR PARTNERS LLP 02/17/2026 357.20 K $7.69 M   106.00% 0.36%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 349.22 K $7.52 M   -41.80% 0.35%

Sarepta Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 539 institutional investors and hedge funds held shares of Sarepta Therapeutics Inc. The most heavily invested institutionals were:

abrdn plc: 2.32 M

UBS Group AG: 2.23 M

Bank of New York Mellon Corp: 687,572

SG Americas Securities, LLC: 559,063

PRINCIPAL FINANCIAL GROUP INC: 509,552

Nuveen, LLC: 186,758

93.19% of Sarepta Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 117.96 M shares in the last 24 months. This purchase volume represents approximately $2.08 B in transactions.